纯度 | >90%SDS-PAGE. |
种属 | Human |
靶点 | MRPL2 |
Uniprot No | Q5T653 |
内毒素 | < 0.01EU/μg |
表达宿主 | E.coli |
表达区间 | 84-202aa |
氨基酸序列 | MGSSHHHHHH SSGLVPRGSH MGSGRDHTGR IRVHGIGGGH KQRYRMIDFL RFRPEETKSG PFEEKVIQVR YDPCRSADIA LVAGGSRKRW IIATENMQAG DTILNSNHIG RMAVAAREGD AHPLGALPVG TLINNVESEP GR |
预测分子量 | 16 kDa |
蛋白标签 | His tag N-Terminus |
缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于MRPL2重组蛋白的3篇参考文献的简要信息(注:以下内容为基于领域知识的模拟文献,实际文献需通过数据库检索确认):
---
1. **文献名称**: "Cloning and Functional Characterization of Human MRPL2: A Mitochondrial Ribosomal Protein Essential for Translation"
**作者**: Zhang Y, et al.
**摘要**: 本研究成功克隆了人源MRPL2基因,并在大肠杆菌系统中表达纯化了重组MRPL2蛋白。通过线粒体功能实验发现,MRPL2缺失导致线粒体翻译活性下降,提示其在核糖体组装及氧化磷酸化复合物合成中起关键作用。
---
2. **文献名称**: "Structural Insights into the Mitochondrial Ribosome: Cryo-EM Analysis of MRPL2 in the Large Subunit"
**作者**: Patel S, et al.
**摘要**: 利用冷冻电镜技术解析了含重组MRPL2蛋白的线粒体核糖体大亚基结构,揭示了MRPL2与邻近蛋白的相互作用界面,为理解线粒体翻译异常相关疾病的分子机制提供了结构基础。
---
3. **文献名称**: "MRPL2 Downregulation Promotes Tumor Metastasis via Mitochondrial Dysfunction in Colorectal Cancer"
**作者**: Liu X, et al.
**摘要**: 通过重组MRPL2蛋白的体外功能实验,发现其在结直肠癌细胞中表达下调会破坏线粒体膜电位,激活ROS信号通路,最终促进肿瘤侵袭转移,表明MRPL2可能作为癌症治疗的潜在靶点。
---
如需获取真实文献,建议通过PubMed或Web of Science以“MRPL2 recombinant protein”或“MRPL2 mitochondrial ribosome”为关键词检索近年研究。
**Background of MRPL2 Recombinant Protein**
MRPL2 (Mitochondrial Ribosomal Protein L2) is a key component of the mitochondrial ribosome, specifically the large (39S) subunit, which plays a critical role in mitochondrial protein synthesis. Mitochondria, the energy-producing organelles in eukaryotic cells, rely on their own translational machinery to produce essential subunits of the oxidative phosphorylation (OXPHOS) complexes. These complexes are vital for ATP generation, underscoring the importance of MRPL2 in maintaining mitochondrial function and cellular energy homeostasis.
Encoded by nuclear DNA, MRPL2 is synthesized in the cytoplasm and subsequently imported into mitochondria. It contributes to the structural integrity of the mitochondrial ribosome and facilitates the translation of mitochondrially encoded mRNA. Mutations or dysregulation in mitochondrial ribosomal proteins, including MRPL2. have been linked to mitochondrial disorders, metabolic diseases, and cancer, often due to impaired OXPHOS activity and increased oxidative stress.
Recombinant MRPL2 protein is produced using heterologous expression systems (e.g., *E. coli* or mammalian cells) to study its biochemical properties, interactions, and role in mitochondrial translation. This engineered protein retains the native structure and function of endogenous MRPL2. enabling researchers to investigate its contribution to ribosome assembly, translational fidelity, and mitochondrial dysfunction in disease models.
Applications of recombinant MRPL2 include *in vitro* binding assays, structural studies (e.g., cryo-EM), and functional analyses to identify therapeutic targets for mitochondrial-related pathologies. Its use also supports the development of diagnostic tools or biomarkers for conditions associated with mitochondrial ribosome defects. Further research on MRPL2 may enhance understanding of mitochondrial translation mechanisms and pave the way for novel interventions in metabolic and degenerative diseases.
×